Table 4 Hs-TnI and hs-TnT levels at peak exercise
From: Troponin I levels in permanent atrial fibrillation—impact of rate control and exercise testing
Treatment | Hs-TnI at peak exercise, ng/L | Hs-TnT at peak exercise, ng/L | Increase in hs-TnI in response to exercise relative to resting level, ng/L | Increase in hs-TnT in response to exercise relative to resting level, ng/L | Increase in hs-TnI in response to exercise relative to resting level, % | Increase in hs-TnT in response to exercise relative to resting level, % |
|---|---|---|---|---|---|---|
Baseline | 6.8 (4.5, 9.7) | 11.0 (7.0, 14.0) | 0.23 (0.14, 0.40)* | 0.06 (−0.05, 0.13) | 23 % | 6 % |
Diltiazem | 5.4 (3.9, 7.4) | 9.0 (7.0, 12.0) | 0.23 (0.12, 0.32)* | 0.11 (0.0, 0.19) | 23 % | 11 % |
Verapamil | 5.3 (3.7, 6.8) | 9.0 (6.0, 12.0) | 0.24 (0.10, 0.35)** | 0.11 (0.0, 0.20) | 24 % | 11 % |
Metoprolol | 5.2 (3.4, 6.9) | 9.0 (7.0, 12.0) | 0.19 (0.09, 0.29) | 0.12 (0.07, 0.22) | 19 % | 12 % |
Carvedilol | 5.1 (3.8, 6.7) | 9.0 (7.0, 13.0) | 0.16 (0.06, 0.27) | 0.13 (0.04, 0.20) | 16 % | 13 % |